CPT® Code 61889

Insertion of skull-mounted cranial neurostimulator pulse generator or receiver, including craniectomy or craniotomy, when performed, with direct or inductive coupling, with connection to depth and/or cortical strip electrode array(s)

The procedure described by CPT® Code 61889 involves the insertion of a skull-mounted cranial neurostimulator pulse generator or receiver, which is a specialized device used primarily for the treatment of epilepsy that does not respond to conventional medication. This procedure is particularly relevant for patients suffering from refractory epilepsy and other neurological disorders. The neurostimulator is designed to be implanted beneath the scalp and within the skull, necessitating a surgical intervention that may include a craniectomy or craniotomy, depending on the specific requirements of the case. During the procedure, the neurostimulator is connected to electrodes that are strategically placed either within the brain tissue or on the surface of the brain. The primary function of this device is to continuously monitor the brain's electrical activity, allowing it to detect the onset of seizures. Once a seizure is detected, the neurostimulator can emit a small electrical signal intended to interrupt or shorten the seizure episode, potentially preventing it altogether. This responsive neurostimulation approach has been shown to reduce the frequency of seizures over time and enhance the overall quality of life for patients. However, it is important to note that the benefits of the device may take several months to manifest, and initial results may not be immediately apparent. Patient engagement plays a crucial role in the effectiveness of this treatment, as it involves regular monitoring and data management, including the daily downloading of information from the neurostimulator to a computer and the use of a magnet to log seizure occurrences. While the procedure can offer significant benefits, there are risks involved, including potential complications such as infection at the implant site, intracranial hemorrhage, or neurological impairment. Additionally, there is a possibility that the procedure may not achieve the desired outcome of reducing or halting seizures in some patients.